Connect with us

Technology

EClinCloud’s eCOA Platform Reaches 177 Countries and Regions as Multi-Regional Trials Drive Electronic Outcome Capture

Published

on

The electronic clinical outcome assessment solution now spans 40+ indication areas and 960+ collaborating sites across four continents, supporting all five COA types with end-to-end scale management, rater training and direct EDC integration.

NINGBO, China, Sept. 30, 2026 /PRNewswire/ — EClinCloud, an AI technology company for clinical research that builds a unified clinical cloud platform and endpoint assessment technology to help improve trial success rates and shorten development cycles, today detailed the global reach of its eCOA solution: the company’s electronic clinical outcome assessment application now operates in 177 countries and regions across four continents, with deployments spanning more than 40 indication areas and 960+ collaborating sites. The expansion tracks two reinforcing industry trends — international multi-regional clinical trials (MRCTs) taking an ever-larger share of new drug development, and outcome capture moving steadily from paper to electronic.

The company’s own registry research puts numbers on the multi-regional shift. Its analysis of industry multinational drug-trial starts found China-inclusive MRCTs growing fivefold in a decade, from 65 starts in 2015 to 322 in 2025 — 28.6% of all such starts — with the median China-inclusive MRCT now spanning 15 countries and 90 facilities, against five countries and 27 facilities for multinational trials without China. On the assessment side, among phase 2/3 drug studies that name a widely used outcome instrument on ClinicalTrials.gov, one in three (33.1%) reports recruitment in multiple countries, and the top 1% span 22 countries or more.

The platform captures every major class of clinical outcome assessment on a single system: patient-reported outcomes (ePRO), clinician-reported outcomes (eClinRO), observer-reported outcomes (eObsRO), performance outcomes (ePerfO) and electronic diaries (eDiary). Because each assessment type implies a different workflow — who answers, on what device, on what schedule — running all five through one platform keeps a multi-country study’s endpoint data on one backbone rather than scattered across point tools.

For MRCTs, deployment breadth is the operational test. EClinCloud delivers multilingual assessments in Chinese, English, Japanese and additional languages, including less widely spoken ones, and provides hardware and software as one service — PC, mobile app and tablet working in concert — so sites and patients in every region capture data the same way. The company’s eCOA experience covers indication areas from CNS, oncology and dermatology to immunology, metabolic and endocrine disorders, respiratory disease and otolaryngology.

Privacy and compliance run through the deployment model. The platform is designed to meet the strict patient-privacy requirements of global data-protection regimes — GDPR in Europe, HIPAA in the United States and China’s Personal Information Protection Law (PIPL) — while accommodating the marked differences between countries and regions in data-collection practice, cultural norms and regulatory enforcement, so that studies keep data consistent and compliant across every site.

“In a multi-regional trial, the hard part is no longer collecting a questionnaire — it is keeping every language, every rater and every device consistent and reliable across dozens of countries at once,” said Michael Qin, PhD, Founder and Chief Executive Officer of EClinCloud. “That is why we built eCOA as an integrated solution with scale management, rater training and data connections around it, rather than as a standalone app.”

Around the software, EClinCloud operates end-to-end scale management drawing on a rich scale library and multi-indication experience: scale due diligence, copyright licensing, translation and linguistic validation, and final delivery handled as one integrated workflow — the decision framework behind it is set out in the company’s report “eCOA Linguistic Validation 2026: Translate, Adapt, License or Revalidate for a Multinational Trial?” The registry shows the scale of that work: the company’s analysis found the VAS named in 19,413 registered studies, the EQ-5D in 8,317 and the SF-36 in 6,626, each carrying its own licensing, translation and validation requirements — a single instrument such as the EQ-5D-5L is maintained in more than 150 languages.

Complementing scale management, the company provides rater training to keep assessment results consistent and reliable across sites and raters — the discipline on which multi-regional endpoint quality depends. Its CNS analysis shows the scale of the need: 48.6% of 5,891 phase 2/3 CNS drug trials name a clinician-rated scale in an outcome, and 26.6% report sites in more than one country — and because public registries carry no field for rater qualification, consistency cannot be demonstrated from public records; it has to be built into the trial itself. The certification, inter-rater reliability and drift-monitoring framework behind the service is set out in the company’s report “Clinical Trial Rater Training 2026: Certification, Inter-Rater Reliability and Drift Monitoring for CNS ClinRO Endpoints.”

Assessment data does not sit in a silo. The eCOA platform integrates directly with EDC so endpoint data flows into a single casebook, while BI analytics assemble operational and clinical data into a full-picture view that supports faster, better-informed study decisions. AI-assisted capture adds a quality layer: in one pediatric Phase II study, AI-guided photo capture with real-time validation raised image pass rates from 40% to about 95% and cut rework cycles from 24–48 hours to under five seconds, with automatic privacy redaction at the point of capture.

In summary, the eCOA solution offers sponsors and study principal investigators running multi-regional trials:

All five COA types — ePRO, eClinRO, eObsRO, ePerfO and eDiary — on one platformMultilingual deployment, with the eCOA app available in 177 countries and regions across four continentsExperience across 40+ indication areas and 960+ collaborating sitesUnified hardware-software delivery spanning PC, mobile app and tabletIntegrated scale management: scale due diligence, copyright licensing, translation and linguistic validation, and deliveryRater training that safeguards the consistency and reliability of assessment resultsDirect EDC integration and BI analytics for decision supportPrivacy and compliance by design: built for GDPR, HIPAA and China’s PIPL, bridging country-to-country differences in data-collection practice, culture and regulatory enforcement to keep data consistent and compliant

These capabilities are backed by EClinCloud’s Deep Research series, which publishes the evidence base behind its platform and services. Recent reports also include “Multiregional Clinical Trials With China Sites in 2026: HGR Approval, PIPL Data Export and What the Registries Show,” on the data-governance decisions MRCT sponsors face, with the full series available at https://www.eclincloud.com/insights.

For demonstrations and partnership inquiries, visit https://www.eclincloud.com/demo.

About EClinCloud

EClinCloud (Ningbo) Technology Co., Ltd. builds a unified, AI-driven clinical cloud platform and endpoint assessment technology for global pharmaceutical and research organizations, with a mission to become a global leader in AI-driven clinical research. Its integrated platform — EDC, RTSM, eCOA, IRC, CTMS, eTMF, resource management and eLearning, with embedded AI agents and BI analytics — supports 1,100+ clinical trials, 300+ organizations and 20,000+ users in 10+ countries and regions. EClinCloud is headquartered in Ningbo, China, with offices in Beijing, Shanghai, Chengdu, Shenzhen and New York. More information is available at https://www.eclincloud.com.

Company Contact

EClinCloud — Global Inquiries
EClinCloud (Ningbo) Technology Co., Ltd.
Phone: +86 186 1698 7169
Email: ecc@eclincloud.com
Web: https://www.eclincloud.com/demo

Media Relations

EClinCloud — Press Inquiries
Phone: +1 415 689 1868
Email: press-media@vayomed.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/eclinclouds-ecoa-platform-reaches-177-countries-and-regions-as-multi-regional-trials-drive-electronic-outcome-capture-302894155.html

SOURCE EClinCloud

Continue Reading

Technology

The Unconventional Route to Fusion Power Just Hit a World First

Published

on

By

VANCOUVER, BC, Oct. 8, 2026 /CNW/ — American News Group News Commentary – General Fusion, the first publicly listed fusion energy company, has reached a world-first milestone by taking a road most of the fusion industry did not. Instead of the superconducting magnets or high-powered lasers used by other approaches, its Magnetized Target Fusion (“MTF”) technology squeezes plasma with a metal wall over milliseconds, and its large-scale demonstration machine, Lawson Machine 26 (“LM26”), has now used that method to heat plasma to more than 12 million degrees Celsius, or more than 1 keV. The Company says only a few fusion companies have ever reached 1 keV, all using other approaches, and that LM26 is the first fusion machine in the world to do it with practical low-speed compression. Some of the market’s most valuable technology companies were built the same way, by backing an unconventional approach long enough for it to work. Active Companies from around the markets with current developments this week include: General Fusion Group Ltd. (NASDAQ: GFUZ), Bloom Energy Corporation (NYSE: BE), ASML Holding N.V. (NASDAQ: ASML), NVIDIA Corporation (NASDAQ: NVDA), and Arm Holdings plc (NASDAQ: ARM).

General Fusion chose its path for a commercial reason. The Company says compressing plasma slowly, rather than in the microseconds or nanoseconds used by other plasma compression technologies, means less required power, less complexity and less cost, and that in its commercial design a liquid metal wall will be used to protect the machine from neutrons, breed fuel, and efficiently capture heat to create steam and spin a turbine. It says reaching 1 keV in LM26 demonstrates the underlying principle of low-speed plasma compression.

General Fusion Achieves World-First 1 keV Electron Temperature Milestone on its Path to Commercial Fusion Power

First of its kind: LM26 is the first fusion machine in the world to reach 1 keV, more than 12 million degrees Celsius, with practical low-speed compression.Two instruments, one picture: Thomson scattering, measured with the UK Atomic Energy Authority (“UKAEA”), recorded approximately 1.1 keV just prior to peak compression, and absolute extreme ultraviolet (“AXUV”) data recorded approximately 1.2 keV at peak compression, closely aligned with the Thomson trend.Behaving as designed: ions heated up to twofold above starting ion temperature, and plasma temperature, density and magnetic field all increased as expected for a stable plasma under compression.First of three: the result achieves the first of three key technical milestones for LM26, with machine upgrades underway to support efforts to reach the second, 10 keV.

General Fusion Group Ltd. (NASDAQ: GFUZ) set 1 keV as LM26’s first major goal because it is an industry-recognized milestone. “No one has reached 1 keV with practical low-speed compression. We did it!” Chief Executive Officer Greg Twinney wrote in a blog post accompanying the announcement. In plain terms, he explained, the team “squeezed a plasma shaped like a cored apple, and it stayed alive while we squeezed it and heated up to more than 12 million degrees.”

To make sure the results would stand up to scrutiny that novel approaches often receive, General Fusion worked with the UKAEA to design, install and commission a gold-standard Thomson scattering system on LM26, and the two organizations measured electron temperature together. The results are detailed in a technical paper co-authored by the UKAEA and a second paper on the AXUV and ion heating data, both posted on the Company’s website and submitted for peer review.

“Reaching more than 1 keV on LM26, alongside confirmed ion heating and corroborating AXUV data, is an important step forward for General Fusion and a meaningful validation of the approach we have spent more than two decades developing. It shows that we are delivering against the technical roadmap we set out for LM26 and gives us greater confidence as we advance toward our next target of 10 keV, the Lawson criterion and practical and economical fusion power at commercial scale. Congratulations to our incredible team, who achieved an industry-defining result on our path to deliver cost-effective, practical fusion energy,” said Greg Twinney, Chief Executive Officer of General Fusion.

Where it goes from here: Planned upgrades to LM26 are now underway to reach the higher compression ratio and plasma density required for 10 keV, roughly 100 million degrees Celsius. After that, the program targets the Lawson criterion, the combination of plasma temperature, density and confinement time that can produce net fusion energy in the plasma, which Mr. Twinney says is targeted by the end of 2028. The Company is also preparing to start its commercial systems program and is working toward operating a first-of-a-kind plant around 2035, with more than two decades of development in Canada behind it. The Honourable Mélanie Joly, Minister of Industry, said: “General Fusion’s latest achievement underscores Canada’s strength as a global leader in clean technology innovation. Advancing fusion energy from the laboratory toward commercial application will unlock significant economic opportunities, drive industrial growth, and support highly skilled jobs.”

General Fusion Group Ltd. (NASDAQ: GFUZ) is a fusion technology development company working to deliver economical, carbon-free fusion energy through its practical Magnetized Target Fusion technology. Its commercialization program is anchored by LM26, the world’s first commercially relevant-scale MTF demonstration machine. General Fusion is the first publicly listed fusion company and was named TIME’s No. 1 GreenTech Company of 2026. More information is available at generalfusion.com.

CONTINUED… Read this and more news from this sector at: americannewsgroup.com

The sector is filled with many happenings this week, and some of those names include:

Bloom Energy Corporation (NYSE: BE)

Bloom Energy built its business on solid-oxide fuel cells, a technology that, according to its annual report, turns fuels including natural gas, biogas and hydrogen into electricity “without combustion or moving parts.” That approach is now winning in one of the fastest-growing power markets: onsite electricity for AI data centers.

Bloom reported record second quarter 2026 revenue of $1.065 billion, up 165.5% year over year, with product revenue up 215.4%, and raised its full-year revenue guidance to between $3.9 billion and $4.2 billion. “Bloom is now a standard for AI onsite power,” said KR Sridhar, Founder, Chairman and Chief Executive Officer.

ASML Holding N.V. (NASDAQ: ASML)

ASML stayed with extreme ultraviolet (“EUV”) lithography through years of development until, in the company’s words, “EUV lithography turned the corner in 2016, when customers began ordering our first production-ready system NXE:3400 in batches.” EUV moved into high volume manufacturing at the beginning of 2020, and today the technology is central to producing the most advanced chips.

On September 8, ASML and Intel Foundry announced that more than one million wafers have been processed on ASML’s newest High NA EUV systems, including volume production on select layers for a subset of Intel Core Ultra Series 3 processors. “The companies building the increasingly complex AI products of the future need manufacturing innovations that are production-ready and easy to use,” said Christophe Fouquet, ASML President and CEO.

NVIDIA Corporation (NASDAQ: NVDA)

Long before AI made it obvious, NVIDIA bet that graphics processors could do far more than graphics. “With our introduction of CUDA in 2006, we opened the parallel processing capabilities of our GPU to a broad range of compute-intensive applications, paving the way for the emergence of modern AI,” the company says in its annual report.

NVIDIA reported second quarter fiscal 2027 revenue of $96.2 billion, up 106% year over year, including Data Center revenue of $89.0 billion, up 117%, and guided third quarter revenue to $108.0 billion, plus or minus 2%. “AI has reached its inflection point. It’s doing useful work. Its tokens are productive and profitable. Now, compute is revenue,” said Jensen Huang, founder and CEO.

Arm Holdings plc (NASDAQ: ARM)

When Arm’s first processor was completed in 1985, much of the industry was focused on high-end workstations and mainframes built on complex instruction sets. Arm went the other way with a simpler design that, as the company recalls on its 40th anniversary, was “low power, fast, and incredibly energy efficient.” That efficiency now underpins a growing share of AI infrastructure.

Arm reported record first quarter fiscal 2027 revenue of $1.29 billion, up 22% year over year, with data center royalties more than doubling, and said demand for its own Arm AGI CPU has grown beyond the $1 billion opportunity it first outlined to more than $2 billion across fiscal 2027 and 2028.

Track the Signals Before the Crowd

The best positioning happens before the crowd catches on. Eagle Eye is a real-time investor signal-intelligence platform that surfaces sentiment shifts, news flow, and trending tickers as they form, so you see attention building instead of chasing it. Watch it live at eagle-eye.dev.

Contact Information:
americannewsgroup.com

Media Contact:
info@americannewsgroup.com

DISCLAIMER

IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of General Fusion Group Ltd. (Nasdaq: GFUZ) (“General Fusion”). The Investment Journal is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities. Creative Direct Marketing Group (“CDMG”) has been retained by General Fusion, pursuant to a services agreement, to provide various marketing and advertising services for an aggregate fee of approximately $315,600, and this article was prepared and published pursuant to that services agreement. The Investment Journal may receive subscription revenue in the future from new subscribers as a result of this advertisement for its newsletter. CDMG will retain any excess sums after all expenses are paid. While this advertisement is being disseminated and for a period of not less than 90 days thereafter, The Investment Journal, CDMG, and their respective officers, principals, or affiliates will not sell securities of General Fusion. If successful, this advertisement will increase investor and market awareness of General Fusion and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, CDMG and The Investment Journal do not purport to provide a complete analysis of General Fusion or its financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly available information about General Fusion. Further, readers are specifically urged to read and carefully consider the risk factors identified and discussed in General Fusion’s Securities and Exchange Commission (“SEC”) filings. Investing in General Fusion is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, CDMG and The Investment Journal cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains forward-looking statements, including statements regarding expected future growth of General Fusion and/or its industry. CDMG and The Investment Journal note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect the actual results of operations of General Fusion. The Investment Journal is the publisher’s trademark. All trademarks used in this advertisement other than The Investment Journal are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. CDMG and The Investment Journal are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks.

PUBLISHER DISCLOSURE: This article is being distributed by American News Group on behalf of Market Equities Limited, a company incorporated under the laws of Ireland (“Market Equities”), which wholly owns and operates American News Group. Market Equities has been paid a fee by Creative Direct Marketing Group (“CDMG”) for General Fusion advertising and digital media services. Market Equities has not been paid a fee directly by General Fusion, and Market Equities is not affiliated with, and is a separate and independent entity from, CDMG, The Investment Journal and General Fusion. Market Equities also expects to receive further compensation as part of an ongoing digital media effort to increase visibility for the company. No further notice will be given, but let this disclaimer serve as notice that all material, including this article, has been reviewed and approved by General Fusion and CDMG.

This relationship and the expectation of future compensation constitute a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged not to use this article as the basis for any investment decision.

Market Equities and its owners, operators, directors, and affiliates do not own any shares of General Fusion, but reserve the right to buy and sell shares of General Fusion at any time without any further notice commencing immediately and ongoing, in the open market, through private placements, and/or through other investment vehicles. There may also be third parties who hold shares of General Fusion and may liquidate their shares, which could have a negative effect on the price of the stock.

Nothing in this publication should be considered personalized financial advice. Market Equities is not licensed under securities laws to address your particular financial situation, and no communication from Market Equities should be deemed personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This publication is neither an offer nor a recommendation to buy or sell any security. Market Equities holds no investment licenses and is neither licensed nor qualified to provide investment advice. While all information is believed to be reliable, it is not guaranteed by Market Equities to be accurate. Individuals should assume that all information contained in this publication is not trustworthy unless verified by their own independent research. Because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.

Cautionary Note Regarding Technical Results. References to plasma heating results, electron temperatures, and technical milestones are based on General Fusion’s own disclosures, including results the company has stated are submitted for peer review. Such results are preliminary in nature and do not guarantee the achievement of subsequent milestones, including the 10 keV heating target or the Lawson criterion. The Renexia S.p.A. framework agreement is milestone-based and remains subject to the parties reaching definitive terms, and references to commercial deployment in the mid-2030s are the Company’s stated target, not a commitment. The collaboration with General Atomics Energy Group relates to plasma diagnostics and does not imply any commercial or financial arrangement beyond that described by the Company. Commercialization of fusion energy remains subject to substantial scientific, engineering, regulatory, and financial risk.

Cautionary Note Regarding the Business Combination. General Fusion became a publicly listed company through a business combination with Spring Valley Acquisition Corp. III. Companies that become public through such transactions may be subject to risks including share price volatility, dilution, limited operating history as a public company, and the restrictions agreed to in connection with the private placement completed in July 2026. Readers are urged to review the risk factors in the Company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Cautionary Note Regarding Referenced Companies. References to Bloom Energy Corporation, ASML Holding N.V., NVIDIA Corporation and Arm Holdings plc are provided solely as market and sector context and as examples of companies that have commercialized their own technical approaches. Those companies are not peers, competitors, or financial comparables of General Fusion Group Ltd. They operate in fuel cell power generation, semiconductor equipment, computing and chip design rather than fusion, are at materially different stages of development and scale, generate substantial revenue, and their technologies, financial results and share performance are not indicative of General Fusion Group Ltd.’s prospects. Fuel cells and semiconductors are different technologies from General Fusion’s Magnetized Target Fusion approach. None of those companies is involved in the production or distribution of this article, and no partnership, affiliation, sponsorship, or endorsement is implied. Figures referenced in this article are as reported by each company and do not represent expectations for any company named, including the profiled company.

Eagle Eye Disclosure. Eagle Eye is an investor signal-intelligence platform affiliated with the publisher of this article, and this reference constitutes promotion of an affiliated product. Eagle Eye is not a broker-dealer, and nothing in the platform or in this article is financial, investment, tax, or legal advice. Data provided in the platform is for informational purposes only and may be delayed. Always do your own research before making any investment decision. See it at eagle-eye.dev.

Cautionary Note Regarding Forward-Looking Statements. Certain statements included in this document are not historical facts but are forward-looking statements within the meaning of the U.S. federal securities laws and “forward-looking information” within the meaning of applicable Canadian securities laws, including statements regarding the outlook for General Fusion’s business, its ability to commercialize Magnetized Target Fusion or any other fusion technology on its expected timeline or at all, the current and expected results of the Lawson Machine 26 programme, the sufficiency and use of its capital, and possible or assumed future results of operations or financial position. These forward-looking statements are provided for illustrative purposes only and must not be relied on as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. These risks and uncertainties include, but are not limited to, the risk that the technical results disclosed herein are not accepted or validated by the broader scientific community (including that the peer review process is unsuccessful); the risk that prior results are not successfully repeated on a larger scale; the risk that the scientific and technical assumptions underlying the results described herein prove to be incorrect; the risk that the Company’s relationship with UKAEA and others deteriorates or terminates, the risk that recent technical results do not prove to be as significant to the operation of LM26 as expected; the risk that the anticipated cost of funding the LM26 program across several planned technical milestones through the end of 2028 is greater than anticipated and additional capital needed by the Company may not be raised on favorable terms, or at all, including as a result of the restrictions agreed to in connection with the private placement the Company closed on July 10, 2026; the risk of adverse changes in general economic, financial market and geopolitical conditions, including conditions affecting capital markets and the clean energy sector; the risk that General Fusion is unable to develop, demonstrate and commercialize MTF technology on the expected timeline or at all, including any failure to achieve the balance of technical objectives of the LM26 program; the risk that General Fusion is unable to begin operating a first-of-a-kind plant around 2035, or at all; the risk that fusion energy does not gain public acceptance, the risk that the scientific and technical assumptions upon which the Company’s MTF technology is based do not prove to be correct, risks associated with the Company’s status as a development-stage company with a history of losses, no revenue from commercial fusion energy operations and no assurance of achieving profitability; the risk that General Fusion’s competitors develop viable fusion technology sooner than we do, the risk of supply chain disruptions, the risk that key technical material and service inputs may not be available when required on reasonable terms or at all, the risk that General Fusion is unable to attract and retain qualified personnel with highly technical expertise, the risk that General Fusion is subject to negative publicity, the risk that General Fusion’s assessment of the total addressable market for fusion energy is incorrect, the risk of changes in the laws and regulations governing the Company’s research and development activities and in the regulation of fusion energy generally; the risk of fluctuations in foreign currency exchange rates, particularly fluctuations in the Canadian dollar relative to the U.S. dollar; the risk that the Company is unable to complete and successfully integrate any future acquisitions; the risk of increased competition from other fusion energy companies and from other clean energy, conventional energy and energy storage technologies; the risk of accidents, earthquake, fires, floods and other natural disasters, the risk that General Fusion’s information technology fails, the risk that General Fusion’s operating expenses are materially higher than forecast, the risk that General Fusion is unable to remediate material weaknesses in General Fusion’s internal controls or identify additional material weaknesses in the future, the risk that General Fusion is unable to adequately protect or enforce its intellectual property rights, the risk of third party claims that General Fusion is infringing or violating another person’s intellectual property rights, the risk that General Fusion’s intellectual property applications are not granted, the risk of a cyber event or privacy breach resulting in an interruption in operations or financial loss, the risk that the trading in General Fusion’s securities may be volatile due to limited volume and the release of a substantial number of Subordinate Voting Shares from a lock-up expiring 180 days after the closing date of its business combination in July 2026; the risk of substantial dilution upon a reduction in the exercise or conversion price of the Multiple Voting Shares and PIPE warrants issued in July 2026 in accordance with the terms thereof; the effectiveness of General Fusion’s internal controls and disclosure controls and procedures; risks arising as a result from the limited experience of certain members of its management team in operating a public company; the risk that the period during which General Fusion will qualify as an emerging growth company under the JOBS Act is reduced; and the risk of litigation, governmental or regulatory proceedings, investigations or inquiries.

You should carefully consider the foregoing factors and the other filings by General Fusion with the SEC, including those described under the heading “Risk Factors.” Neither General Fusion nor any other party undertakes to update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required in accordance with applicable laws. This document is governed by the laws of Ireland.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-unconventional-route-to-fusion-power-just-hit-a-world-first-302901973.html

SOURCE American News Group

Continue Reading

Technology

RKD Group Welcomes Kelly Kennedy as Chief Financial Officer

Published

on

By

PLANO, Texas, Oct. 8, 2026/PRNewswire/ — RKD Group, North America’s top fundraising and marketing services firm supporting mission-driven organizations, announced today that Kelly Kennedy has joined the company as Chief Financial Officer. In this role, Kennedy will lead RKD’s financial strategy and support the company’s continued growth in service of nonprofit organizations and the missions they advance.

“Kelly brings a rare combination of strategic financial leadership and experience guiding complex organizations through growth and change,” said Kevin Jones, CEO of RKD Group. “Her perspective will strengthen our leadership team as we continue investing in the people, capabilities and innovation that help our nonprofit clients accelerate their impact.”

Kennedy joins RKD following nearly three years as Chief Financial Officer at Netchex, a payroll and HCM software provider. Earlier in her career, Kennedy held key financial leadership roles at Shopify, PepsiCo and Target.

Her experience spans financial planning and analysis, capital planning, operational finance, strategic decision-making, M&A and post-acquisition integration.

“I’m thrilled to join RKD Group at a time when the need for strong, sustainable nonprofit organizations has never been greater,” Kennedy said. “RKD’s commitment to helping mission-driven organizations accelerate their impact is deeply compelling, and I look forward to working with the team to support the company’s growth and unlock even greater value for our clients.”

About RKD Group
Founded in 1970 to serve the needs of nonprofit clients, RKD Group is a leading fundraising and marketing firm serving mission-driven organizations across the United States and Canada. The first agency to identify and adapt to the changes in technology and culture that impact philanthropy, RKD helps organizations including Susan G. Komen, The Salvation Army, The Pancreatic Cancer Action Network, Toys for Tots, Feed the Children, Guide Dogs for the Blind, Food Bank for New York City, and more grow through integrated fundraising strategy, omnichannel marketing, analytics, donor engagement, creative services, and digital transformation. To learn more, visit rkdgroup.com.

Media Contact

Ronnie Richard
424342@email4pr.com
(800) 222-6070

View original content to download multimedia:https://www.prnewswire.com/news-releases/rkd-group-welcomes-kelly-kennedy-as-chief-financial-officer-302901963.html

SOURCE RKD Group

Continue Reading

Technology

Inside Classic Firearms’s Brand Refresh: A Legacy Retailer’s Approach to Modernizing Its Identity

Published

on

By

MONROE, N.C., Oct. 8, 2026 /PRNewswire/ — Today, Classic Firearms unveiled a refreshed brand identity anchored by a new logo, nearly four decades after a local enthusiast set out to make high-quality, and in some cases hard-to-find, firearms available to the broader public at reasonable prices. The update offers a case study in how a legacy digital retailer approaches modernization without losing sight of the original vision that has carried the business through millions of orders since its founding in 1989.

Rather than a reaction to a single moment, the refresh represents a deliberate step the company took to align its visual identity with the scale it has reached over time and reconnect to the company’s core values. The process focused on preserving the qualities customers already associate with the brand, including access to unique and hard-to-find products, great deals thanks to deep, long-standing relationships with distributors and direct relationships with importers and manufacturers, a large, nationwide Federal Firearms License dealer network, and a high-tech fulfillment system designed to process orders quickly and accurately, while updating how those qualities are expressed visually and verbally.

“A refresh like this only works if it grows out of what already makes the brand recognizable. We weren’t interested in reinventing who we are. We are embracing our history, our core values, our experiences and what we’ve learned, our relationships, our customers, everything that makes us Classic and this new visual identity represents that,” said Ryan Haas, President of Classic Firearms. 

The company’s core values, community focus,  and commitment to providing the best customer service experience and product selection remain unchanged following the update. For marketers and brand strategists, the Classic Firearms refresh illustrates a broader pattern among legacy digital-first retailers, evolving a brand’s presentation to match its growth, without disrupting the trust and recognition already built with existing customers.

The refreshed identity will roll out across Classic Firearms’s website, packaging, and marketing channels in the coming weeks.

About Classic Firearms
Classic Firearms is a direct-to-consumer online retailer offering an extensive selection of firearms, ammunition, and related gear, including hard-to-find and specialty inventory secured through long-standing industry relationships. Known for fast shipping and high order accuracy, Classic Firearms has served firearms enthusiasts and everyday buyers since 1989 as one of the industry’s original online retailers.

Media Contact

Grant Ruder
Senior Director, Marketing
(813) 825-5513
424371@email4pr.com
https://www.classicfirearms.com/ 

View original content to download multimedia:https://www.prnewswire.com/news-releases/inside-classic-firearmss-brand-refresh-a-legacy-retailers-approach-to-modernizing-its-identity-302901977.html

SOURCE Classic Firearms

Continue Reading

Trending